Lung valve treatment for emphysema with specific lung anatomy
Part of Lungs & breathing clinical trials.
This trial tests a one-way lung valve system to reduce over-inflated lung areas in people with emphysema. It’s aimed at patients whose lung scans suggest they may benefit from “fissure completion” to improve airflow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 40 and 75 years old.
- Be on a stable, low dose of prednisone (or similar steroid) for your COPD; less than 10 mg per day.
- Not smoke for at least 4 months before screening, and agree not to smoke during the study.
- Have finished supervised pulmonary (breathing) rehabilitation within the last 12 months, or keep up maintenance breathing rehab if it was longer ago.
- Be up to date on pneumococcal and flu vaccines.
- Be able to attend all required follow-up visits and tests during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a procedure to “complete” a lung fissure in people whose prior bronchoscopic lung volume reduction did not work as well as hoped. It may help reduce persistent shortness of breath, but eligibility depends on your lung test results and overall heart/lung safety.
This study looks at lung tissue taken out after a treatment that places a one-way lung valve to help breathing. They want to learn how the valve affects the airway and lung over time.
This trial tests a new treatment called AeriSeal to seal off damaged parts of the lung in people with severe emphysema. It aims to help you breathe better by reducing the amount of air trapped in your lungs.
This trial tests a new implant for people with severe emphysema. It aims to see if the implant can help you breathe easier and walk farther.
This trial tests a two-step procedure that uses small valves and a blood patch to close persistent air leaks in the lung. It could be an option for people who cannot have or don't want surgery.
This trial tests a surgical procedure to split the fissure between lung lobes in people with severe COPD who did not get better after endobronchial lung volume reduction (EBLVR). The goal is to improve breathing and quality of life.
Hear when a new Emphysema or COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.